Budesonide is marketed under several brand names, depending on its formulation and intended use. Common brand names include:
What are the different forms of Budesonide available?
Budesonide is available in various forms, including inhaled, nasal, and oral formulations. These are prescribed for different medical conditions.
What conditions is inhaled Budesonide used for?
Inhaled budesonide is primarily used as a maintenance therapy for asthma in adults and children. It helps to prevent asthma attacks by reducing airway inflammation. Brand names for inhaled budesonide include Symbicort (in combination with formoterol) and Pulmicort [1].
What is nasal Budesonide used for?
Nasal budesonide is used to treat symptoms of allergic rhinitis, such as sneezing, runny nose, and nasal congestion. Rhinocort Aqua is a brand name for a nasal spray formulation of budesonide [2].
When was Budesonide first approved?
The first approval for budesonide in the United States was for an inhaled formulation in 1997 [1].
What are the brand names for oral Budesonide?
Oral budesonide formulations are used to treat conditions like Crohn's disease and ulcerative colitis. Entocort EC is a brand name for an extended-release oral capsule of budesonide [3].
Are there other uses for Budesonide?
Beyond asthma and inflammatory bowel disease, budesonide is also used in other contexts. For example, budesonide is a component in some treatments for eosinophilic esophagitis.
Where can I find information on Budesonide patents?
Information regarding patents for budesonide formulations and their expiration can be found through resources like DrugPatentWatch.com [4]. This site tracks drug patents, exclusivity periods, and potential generic entry dates, which can be important for understanding market dynamics and availability.